Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call

×

Error message

  • Notice: Undefined property: stdClass::$ds_changed in eval() (line 16 of /var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined property: stdClass::$ss_search_api_url in eval() (line 20 of /var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined property: stdClass::$tm_title in eval() (line 20 of /var/www/7/modules/php/php.module(80) : eval()'d code).

Charles River Laboratories International, Inc. (NYSE: CRL) will release first-quarter 2024 financial results on Thursday, May 9th, before the market opens.

Metadata
Provider: 
Business Wire, Inc.Business Wire, Inc.
Retrieved on: 
Friday, April 12, 2024
Information
Tags: 
Biotechnology, General Health, Medical Devices, Health, Pharmaceutical, CRL
Geotags: 
UNITED STATES, NORTH AMERICA, MASSACHUSETTS
⚠ partially generated by AI ↴
Organisation: 
CHARLES RIVER LABORATORIES INTERNATIONAL, CHARLES RIVER LABORATORIES INTERNATIONAL, INC., CHARLES RIVER
Stock Symbol: 
NYSE:CRL
Summary
Key Points: 
  • Charles River Laboratories International, Inc. (NYSE: CRL) will release first-quarter 2024 financial results on Thursday, May 9th, before the market opens.
  • A conference call has been scheduled to discuss this information on Thursday, May 9th, at 8:30 a.m.
  • Investors will have the opportunity to listen to a live webcast of the conference call through the Investor Relations section of the Company's website at ir.criver.com .
  • A replay will be accessible through the same website.


Charles River Laboratories International, Inc. (NYSE: CRL) will release first-quarter 2024 financial results on Thursday, May 9th, before the market opens. A conference call has been scheduled to discuss this information on Thursday, May 9th, at 8:30 a.m. ET.

Investors will have the opportunity to listen to a live webcast of the conference call through the Investor Relations section of the Company's website at ir.criver.com. A replay will be accessible through the same website.

About Charles River

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.

Copyright: 
Copyright Business Wire 2024